nSTRIDE APS is an autologous (from your own body) therapy which is designed to treat joint pain associated with Osteoarthritis. In laboratory testing, nSTRIDE APS has been shown to protect cartilage tissue. This protective quality may slow the progression of arthritis as well.
The nSTRIDE APS injection treatment is designed to alleviate pain and bring balance back to your inflamed hip or knee joint by introducing high levels of “good” proteins concentrated from your own blood. These good proteins can block the “bad” proteins responsible for the inflammatory condition in your joint. At the same time, nSTRIDE APS also concentrates growth factors which are beneficial for cartilage health.
In an osteoarthritic knee, inflammatory cytokines (“bad” proteins) outnumber anti-inflammatory cytokines (“good” proteins) causing an imbalance, resulting in cartilage degeneration which in turn causes pain. The “bad” proteins attack the cartilage and must be stopped simultaneously to decrease pain and slow cartilage degeneration.
The prepared nSTRIDE APS introduces high levels of “good” proteins that is designed to overwhelm and block the “bad” proteins. These “good” proteins may help stimulate a biologic cascade which has been shown to block cartilage destruction in osteoarthritis. This most probably results in reduction in joint pain and help improve function. The ongoing destruction of cartilage may also be slowed.
Unlike other traditional studies, laboratory, animal, and human studies have shown that nSTRIDE APS has decreased pain and slowed cartilage degeneration. therapies.
- Significantly Reduces Pain Associated with Knee OA up to 2 years.
- Significantly improves Mobility in the Knee Joint associated with OA.
- 70% Improvement in Knee Pain at 2 years following a Single Injection.
nSTRIDE may significantly reduce or eliminate the pain and reduce the stiffness associated with osteoarthritis, thus help to restore mobility and flexibility.
It is important to remember that there is no cure for osteoarthritis but successful treatment with nSTRIDE APS may reduce or relieve your pain which may increase you your mobility and comfort. Your osteoarthritis may not improve or may get worse.
The treatment is designed to be a single injection therapy in the out-patient clinic setting. Blood is withdrawn like a simple blood test, the clinician processes the patient’s blood to concentrate white blood cells, platelets, and plasma proteins into a small volume of plasma. It is autologous (obtained from your own body), not a synthetic therapy and does not require cell culture.
The prepared nSTRIDE APS (approximately 2-3 ccs) is administered as a joint injection directly into the knee joint cavity, the injection offers:
- Anti-inflammatory effects
- Joint pain reduction
- Promotion of cartilage health
- Improvement of joint function
You may experience some side effects like bruising, local pain or swelling associated with the site of the blood withdrawal or knee injection.